Results: 927 news stories
UT Health San Antonio and UTSA athletics partnership features top-tier care and discounted game tickets
UT Health San Antonio has recommitted itself for the fourth year as the exclusive official health care partner of The University of Texas at San Antonio athletics programs, including football, basketball, baseball, volleyball and soccer programs. As part of the partnership, the two-time conference champion UTSA football team will take the home field on […]
$2 million CPRIT award brings top cancer researcher to UT Health San Antonio
As part of the $52 million Cancer Prevention and Research Institute of Texas (CPRIT) grant funding round announced in May, The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a $2 million CPRIT recruitment (CPRIT Scholar) funding award to bring top cancer researcher, Maria Falzone, PhD, to the […]
Study: Dysregulation in bioenergetic process linked to rapid onset of non-alcoholic fatty liver disease
Every molecule in cellular metabolism has a role to play. A breakdown in any part of this delicate balance can cause a chain reaction of negative health conditions. Acetyl-CoA is a necessary molecule in the bioenergetic process because it converts fuel sources into energy for the cells. For mammals, this fuel is usually glucose, which […]
Study explores mechanisms behind chronic pain related to sleep apnea
Lack of oxygen can sensitize nerve cells, leading to long-term pain More than 100 million people worldwide are affected by obstructive sleep apnea. This health condition causes a person to stop breathing numerous times while they are sleeping. Reduced sleep time and sleep quality can lead to numerous health problems including obesity, high blood pressure, […]
UT Health San Antonio’s Brett Ginsburg selected for Wellcome Leap Untangling Addiction program
Study will evaluate biomarkers and novel treatments for alcohol use disorder Brett Ginsburg, PhD, director of the Biochemical Pharmacology Analytical Laboratory at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), was selected as a performer with the Wellcome Leap Untangling Addiction program. Wellcome Leap is a U.S.-based nonprofit organization […]
WOAI-TV: Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials
This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment. Watch Now
Clinical Trials Arena: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
MSN.com: UT Health San Antonio study: HIV drug may be effective against Alzheimer’s disease
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
AHRQ: Identifying and Disseminating Best Practices To Treat Long COVID
Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Physical Medicine and Rehabilitation, and director of its long COVID clinics, was featured in this story. Read More
Mirage News — UT Health SA: Drug Shows Promise for Breast Cancer Brain Tumors
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
Science Magazine: Drug shows promise for treating brain tumors resulting from breast cancer, UT Health San Antonio trial reports
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
Medical Xpress: Drug shows promise for treating brain tumors resulting from breast cancer, trial reports
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
eCancer: Drug shows promise for treating brain tumours resulting from breast cancer
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
Technology Networks: Drug Shows Promise for Brain Tumors Spread From Breast Cancer in Trial
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
Non-invasive treatment provides relief for osteoarthritis pain
Patricia Abrego’s journey to a clinical study using radiation therapy to relieve osteoarthritis joint pain began when she was 10 years old. Like most children living in a state where snowy winters were a norm, Abrego was doing what most kids do: playing. “The leaves were covered with snow, and they made good bumps […]
UT Health San Antonio scientist awarded $300,000 grant to study effect of Spanish-language interpretation on child mental health outcomes
A researcher with (UT Health San Antonio) was awarded a $300,000 research project grant through the Texas Child Mental Health Care Consortium’s New and Emerging Children’s Mental Health Research initiative. Jessica Sandoval, MD, associate clinical professor with the Department of Psychiatry and Behavioral Sciences, Division of Child and Adolescent Psychiatry, in the Joe R. and […]
Knowable Magazine: Understanding the sudden rise of type 2 diabetes in children
Luisa M. Rodriguez, MD, MS, clinical associate professor and pediatric endocrinology medical director, was quoted in this article. Read More
Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials
Scientists from The University of Texas Health Science Center at San Antonio, also known as UT Health San Antonio, led a pilot study of the Food and Drug Administration-approved antiretroviral drug lamivudine, to determine if it could be a potential treatment for Alzheimer’s disease. Almost half of what makes up the human genome are […]
UT Health San Antonio faculty member helps create universal long COVID definition
A report released June 11 by the National Academies of Sciences, Engineering and Medicine (NASEM) provides a working definition of long COVID. Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Rehabilitation Medicine in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San […]
Alternatives for treatment-resistant depression offer hope
Carey Calvin was at the lowest point in his life two years ago. After a childhood filled with physical and emotional abuse and years of antidepressant medications and therapies that were not working, Calvin was ready to give up. “It was the first time I felt like my family and the things closest to […]